2016
DOI: 10.1007/s13277-015-4396-9
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer

Abstract: Colorectal cancer (CRC) has a high prevalence and mortality rate. Biomarkers for predicting the recurrence of CRC are not clinically available. This study investigated the role of circulating miR-15b in the prediction of CRC recurrence and the associated mechanism. miR-15b levels in plasma and tissues were measured by real-time PCR. Metastasis suppressor-1 (MTSS1) and Klotho protein expression were detected by Western blot and immunohistochemistry. Invasion and migration of CRC tumor cells were measured by tra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
44
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(46 citation statements)
references
References 30 publications
2
44
0
Order By: Relevance
“…Furthermore, miR-590-5p and miR-15b-5p were slightly but significantly elevated in the HT-29 cell line respect to non- tumour cells. Whereas it is widely known that miR-15b is elevated in samples from patients with colon cancer3233, to our knowledge, this is the first implication of miR-590-5p overexpression in colon cancer cells. Moreover, it has been demonstrated that miR-590-5p is overexpressed in renal carcinoma cell lines34, hepatocellular35 and cervical cancer tissue36.…”
Section: Discussionmentioning
confidence: 65%
“…Furthermore, miR-590-5p and miR-15b-5p were slightly but significantly elevated in the HT-29 cell line respect to non- tumour cells. Whereas it is widely known that miR-15b is elevated in samples from patients with colon cancer3233, to our knowledge, this is the first implication of miR-590-5p overexpression in colon cancer cells. Moreover, it has been demonstrated that miR-590-5p is overexpressed in renal carcinoma cell lines34, hepatocellular35 and cervical cancer tissue36.…”
Section: Discussionmentioning
confidence: 65%
“…The ability of MTSS1 knockdown to rescue the cells from the functional consequences of Akt2 loss pointed to this scaffolding protein as a major mediator of the effects of Akt2 deficiency in CRC cells. In this regard, a role for MTSS1 in inhibition of cell proliferation and migration/invasion has been demonstrated by others in CRC cells 43,45,46 and various other cancer types. 34,64,65 However, to our knowledge, our study provides the first evidence for a pro-apoptotic function of MTSS1 in cancer cells, as indicated by the ability of MTSS1 knockdown to rescue GEO and CBS cells from the cell death-inducing effects of Akt2 knockdown.…”
Section: Discussionmentioning
confidence: 74%
“…Although the mechanism for suppression of MTSS1 mRNA by Akt2 remains to be determined, based on evidence that MTSS1 is a target for miR-23a, miR-135a, miR-135b and miR-15b in CRC cells, all of which have been implicated in promoting metastasis in diverse in vitro and in vivo experimental models, it is possible that microRNAs mediate the effect. 42,43,45,46 Consistent with this possibility, Akt isoforms have been shown to differentially regulate the expression of multiple microRNAs involved in the epithelial/ mesenchymal transition, cell motility, invasion and metastasis. Akt2 was shown to decrease the abundance of miR200 family members in breast cancer cells, promoting epithelial/mesenchymal transition and enhanced cell migration and tumor progression.…”
Section: Discussionmentioning
confidence: 80%
“…In the present study, the expression of miR-15 was decreased in the majority of colon cancer tissues compared with para-cancerous tissues, supporting the role of miR-15 as a tumour suppressor in colon cancer. miR-15 is able to regulate chemoresistance in addition to regulating cell proliferation, apoptosis, angiogenesis and metastasis (30)(31)(32)(33). Xia et al (34) identified that miR-15 may enhance the sensitivity of gastric cancer cells to anticancer drugs by targeting BCL2 and promoting apoptosis.…”
Section: Discussionmentioning
confidence: 99%